RxDoctor Payments Data

Lana Law

Internal Medicine · Canton, GANPI 1164443115

Payments from drug & device makers

$1,069in general payments, 2019–2025

Across 61 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$279
  • Novo Nordisk$197
  • GSK$143
  • Novartis$130
  • Nevro Corp.$68
  • Lilly USA, LLC$45
  • plus $206 from 9 others

What the payments were for

  • Food & beverage$1,069100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,069 in reported general payments places this provider in the 65th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$90,392
Medicare patients
131
Services billed
2,786

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide59$67,394
JanuviaSitagliptin Phosphate27$32,611
OzempicSemaglutide23$28,987
EliquisApixaban14$17,799
JardianceEmpagliflozin16$14,122
XareltoRivaroxaban12$6,758
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$6,197
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$4,585
Humalog Kwikpen U-100Insulin Lispro11$2,733
SymbicortBudesonide/Formoterol Fumarate13$2,697
Levothyroxine Sodium246$2,124
Rosuvastatin Calcium181$2,022
Pantoprazole Sodium127$1,764
Atorvastatin Calcium167$1,741
Losartan Potassium115$1,678

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$45$67,39459 claims
Novo NordiskOzempic$197$28,98723 claims
PfizerEliquis$43$17,79914 claims
AstraZenecaSymbicort$14$2,69713 claims
AbbVieSynthroid$29$1,18820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Canton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →